Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China
· Delayed Price · Currency is CNY 93.57
+1.50 (1.63%)
Apr 29, 2026, 3:00 PM CST
SHA:688578 Revenue
Shanghai Allist Pharmaceuticals had revenue of 1.58B CNY in the quarter ending March 31, 2026, with 44.19% growth. This brings the company's revenue in the last twelve months to 5.67B, up 44.95% year-over-year. In the year 2025, Shanghai Allist Pharmaceuticals had annual revenue of 5.19B with 45.80% growth.
Revenue (ttm)
5.67B
Revenue Growth
+44.95%
P/S Ratio
7.30
Revenue / Employee
2.85M
Employees
1,989
Market Cap
41.43B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Asymchem Laboratories (Tianjin) | 6.67B |
| Hebei Changshan Biochemical Pharmaceutical | 928.01M |
| Shanghai RAAS Blood Products | 7.35B |
| Chongqing Zhifei Biological Products | 10.91B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.32B |
| Pharmaron Beijing | 14.10B |
| Beijing Wantai Biological Pharmacy Enterprise | 1.82B |
| Beijing Tiantan Biological Products | 6.17B |